Search research articles
Contact Us
Filters
Showing results (1331-1340 of 1,467) with videos related to
Page
of 147
Sort By:
Nature Methods
|
September 14, 2023
Crystal ribcage: a platform for probing real-time lung function at cellular resolution
Rohin Banerji, Gabrielle N Grifno, Linzheng Shi, et al.
Annals of the Rheumatic Diseases
|
April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
G K Bertsias, J P A Ioannidis, J Boletis, et al.
Frontiers in Immunology
|
October 10, 2024
Plasma adenosine deaminase-1 and -2 activities are lower at birth in Papua New Guinea than in The Gambia but converge over the first weeks of life
Thomas S Kouyate, Athena N Nguyen, Alec L Plotkin, et al.
Annals of the Rheumatic Diseases
|
February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018
Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
Journal of Autoimmunity
|
May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritis
Victoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases
|
January 30, 2019
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus
Sara K Tedeschi, Sindhu R Johnson, Dimitrios T Boumpas, et al.
Annals of the Rheumatic Diseases
|
April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024
Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
The Journal of Rheumatology
|
December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria
Sindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Annals of the Rheumatic Diseases
|
August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Page
of 147
Search research articles
Search
Showing results (1331-1340 of 1,467) with videos related to
Sort By:
Page
of 147
Nature Methods
|
September 14, 2023
Crystal ribcage: a platform for probing real-time lung function at cellular resolution
Rohin Banerji, Gabrielle N Grifno, Linzheng Shi, et al.
Annals of the Rheumatic Diseases
|
April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
G K Bertsias, J P A Ioannidis, J Boletis, et al.
Frontiers in Immunology
|
October 10, 2024
Plasma adenosine deaminase-1 and -2 activities are lower at birth in Papua New Guinea than in The Gambia but converge over the first weeks of life
Thomas S Kouyate, Athena N Nguyen, Alec L Plotkin, et al.
Annals of the Rheumatic Diseases
|
February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018
Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
Journal of Autoimmunity
|
May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritis
Victoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases
|
January 30, 2019
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus
Sara K Tedeschi, Sindhu R Johnson, Dimitrios T Boumpas, et al.
Annals of the Rheumatic Diseases
|
April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024
Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
The Journal of Rheumatology
|
December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria
Sindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Annals of the Rheumatic Diseases
|
August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Page
of 147